Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities
Due to the speed, efficiency, relative risk, and lower costs compared to traditional drug discovery, the prioritization of candidate drugs for repurposing against cancers of interest has attracted the attention of experts in recent years. Herein, we present a powerful computational approach, termed...
Saved in:
| Main Authors: | Jieyi Di, Baotong Zheng, Qingfei Kong, Ying Jiang, Siyao Liu, Yang Yang, Xudong Han, Yuqi Sheng, Yunpeng Zhang, Liang Cheng, Junwei Han |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-10-01
|
| Series: | Molecular Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/1878-0261.12564 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Literature data-based de novo candidates for drug repurposing
by: Xianglong Liang, et al.
Published: (2025-08-01) -
Integrative genomic and bioinformatic prioritization of drug repurposing candidates for prostate cancer
by: Lalu Muhammad Irham, et al.
Published: (2025-08-01) -
Experimental Justification of Reprofiling of the Drug Maxar® for the Treatment of Viral Infections
by: T. S. Zaporozhets, et al.
Published: (2023-10-01) -
Drug Repurposing for Rare Orphan Diseases Using Machine Learning Techniques
by: Rajesh Manicavasaga, et al.
Published: (2022-05-01) -
Filling the gap in CNS drug development: evaluation of the role of drug repurposing
by: A. Caban, et al.
Published: (2017-01-01)